AbbVie vs Mastercard: Founders, CEOs and History

Company facts

Founders

CEOs and their tenures

Timeline: AbbVie and Mastercard side by side

1. 1966Mastercard

   Interbank Card Association Takes Shape

   A group of U.S. Banks formed the Interbank Card Association to make card acceptance work across institutions rather than inside isolated bank programs.

2. 1968Mastercard

   Master Charge Brand Adopted

   The association adopted the Master Charge name and interlocking-circle design to give member banks a stronger shared identity. A common brand made the network easier for merchants and consumers to recognize as acceptance expanded beyond local bank programs.

3. 1979Mastercard

   Master Charge Becomes MasterCard

   The network changed its name from Master Charge to MasterCard as it became more international. The rebrand simplified recognition and helped the company present itself as a global acceptance network rather than a domestic bank-card association.

4. 2002Mastercard

   Europay Merger and Corporate Conversion

   MasterCard merged with Europay International and converted from a membership association into a private share corporation. That structure prepared the company for public-market ownership and a more independent investment agenda.

5. 2006Mastercard

   Initial Public Offering on the NYSE

   MasterCard priced its initial public offering at $39 per share and listed on the New York Stock Exchange under the symbol MA.

6. 2013AbbVie

   AbbVie Launches as an Independent Company

   AbbVie launched after Abbott Laboratories separated its research-based pharmaceutical business and began NYSE trading under ABBV.

7. 2015AbbVie

   Pharmacyclics Acquisition Completed

   AbbVie completed its acquisition of Pharmacyclics, adding Imbruvica and expanding its hematologic oncology business.

8. 2017Mastercard

   Vocalink Expands Real-Time Payments

   Mastercard completed its Vocalink acquisition after announcing a deal for 92.4 percent of the U.K. Payments infrastructure company for about $920 million.

9. 2019AbbVie

   Skyrizi Receives Initial U.S. Approval

   The FDA approved Skyrizi for adults with moderate to severe plaque psoriasis in April 2019.

10. 2019AbbVie

    Rinvoq Receives Initial U.S. Approval

    The FDA approved Rinvoq for adults with moderate to severe rheumatoid arthritis in August 2019.

11. 2020AbbVie

    Allergan Acquisition Completed

    AbbVie completed the Allergan acquisition, adding neuroscience, eye care, and Allergan Aesthetics products including Botox and Juvederm.

12. 2020Mastercard

    Finicity Strengthens Open Banking

    Mastercard completed the acquisition of Finicity, a North American financial data and open banking platform. The deal added consumer-permissioned data connectivity for lending, account verification, personal finance, and account-based payment use cases.

13. 2021Mastercard

    Michael Miebach Becomes CEO

    Michael Miebach became chief executive officer on January 1, 2021 after serving as chief product officer and president.

14. 2021Mastercard

    Nets Account-to-Account Business Closes

    Mastercard completed the acquisition of the majority of Nets' Corporate Services business, adding clearing and settlement instant payment infrastructure, bill payment, and e-invoicing capabilities.

15. 2023AbbVie

    U.S. Humira Biosimilar Competition Begins

    Humira began facing U.S. biosimilar competition, and AbbVie reported a subsequent decline in Humira revenue.

16. 2024AbbVie

    ImmunoGen Acquisition Completed

    AbbVie completed its acquisition of ImmunoGen, adding Elahere and antibody-drug conjugate programs.

17. 2024AbbVie

    Robert A. Michael Becomes CEO

    Robert A. Michael succeeded Richard A. Gonzalez as chief executive officer effective July 1, 2024.

18. 2024AbbVie

    Cerevel Therapeutics Acquisition Completed

    AbbVie completed its acquisition of Cerevel Therapeutics, adding clinical-stage neuroscience programs.

19. 2024Mastercard

    Recorded Future Adds Threat Intelligence

    Mastercard completed the acquisition of Recorded Future, adding AI-enabled threat intelligence to its cybersecurity, identity, and real-time fraud scoring services.

20. 2025AbbVie

    Robert A. Michael Becomes Chairman

    Robert A. Michael added the chairman role effective July 1, 2025, when Richard A. Gonzalez retired from the board.

21. 2025AbbVie

    FY2025 Revenue Reaches $61.160 Billion

    AbbVie reported FY2025 net revenue of $61.160 billion and net income of $4.226 billion.

22. 2025Mastercard

    $32.8B FY2025 Net Revenue

    Mastercard reported $32.791 billion in FY2025 net revenue and $14.968 billion in net income.

23. 2026AbbVie

    Q1 2026 Revenue Reaches $15.002 Billion

    AbbVie reported first-quarter 2026 net revenue of $15.002 billion, up 12.4 percent on a reported basis.

24. 2026Mastercard

    BVNK Adds Stablecoin Infrastructure

    Mastercard closed its acquisition of stablecoin infrastructure firm BVNK on August 3, 2026, for up to $1.8 billion including contingent payments. The deal extends the company's network to on-chain payments alongside cards and bank transfers.

Acquisitions

Questions about AbbVie vs Mastercard